Switzerland· 21037028
Néo-Mercazole, Tabletten
A carbimazole product containing carbimazolum, registered in Switzerland by Advanz Pharma Specialty Medicine Switzerland GmbH and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 8 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Carbimazole is registered in 8 of 19 countries.
Countries holding a registration under ATC H03BB01 (carbimazole), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 4 of them publish a price we can compare per daily dose
Carbimazole · ATC H03BB01
8 / 19 countries
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Norwayprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of carbimazole costs, country by country.
Normalised to the WHO defined daily dose (15 mg), the median price runs from $0.15 in France to $0.94 in Switzerland — a ×6.3 gap.
- Switzerland: $0.94 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Carbimazole · price per daily dose (15 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.94
- FR France$0.15
The record
At a glance
Swissmedic (Switzerland)- Active substance
- carbimazolum
- Manufacturer
- Advanz Pharma Specialty Medicine Switzerland GmbH
- Country
- Switzerland (CH)
- ATC code
- H03BB01
- ATC class
- Carbimazole
- Defined daily dose
- 15 mg, O
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin768021037028050 StkCHF 12.95
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Carbimazole in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomCarbimazole 5mg tabletsPilsco Ltd
- IrelandCarbimazole 5 mg TabletsRenata Pharmaceuticals (Ireland) Limited
- SpainNEO-TOMIZOL 5 mg COMPRIMIDOSFerrer Internacional S.A.
- FinlandTyrazolOrion Corporation
- FranceNEO-MERCAZOLE 5 mg, compriméAMDIPHARM
- NorwayCarbimazolsanofi-aventis (2)
- GermanyCarbimazol 1 A Pharma1 A Pharma Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Cyprus · Carbimazole Remedica
- Germany · Carbimazol 1 A Pharma, Carbimazol Aristo
- Denmark · Neo-Mercazole
- Spain · Neo-Tomizol
- Finland · Tyrazol
- France · Neo-Mercazole
- United Kingdom (Northern Ireland) · Carbimazole, Carbimazole Activase Pharmaceuticals
- Greece · Thyrostat
- Ireland · Carbimazole Essential Healthcare, Carbimazole Renata Pharmaceuticals (Ireland)
- Malta · Carbimazole Remedica, Carbimazole Renata Pharmaceuticals (Ireland)
- Norway · Neo-Mercazole
- Portugal · Carbimazole Renata, Carbimazole Renata 20 Mg Comprimidos
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fc78c127-03f1-4e44-88a1-0cf81a546ed4 GET /v1/drugs/fc78c127-03f1-4e44-88a1-0cf81a546ed4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "carbimazolum 5 mg",
"valid_from": "1955-03-15",
"limitations": null,
"galenic_form": "Tabl 5 mg",
"therapeutic_area": null,
"sl_inclusion_date": "1955-03-15",
"self_retention_pct": 10
}See everything about carbimazole.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.